Healthcare

Lupin gets USFDA nod for antidepressant drug

Updated : November 27, 2018 06:15 AM IST

The company has received approval from the United States Food and Drug Administration (USFDA) to market its generic Clomipramine Hydrochloride capsules USP in the strengths of 25 mg, 50 mg, and 75 mg, Lupin said in a filing to BSE.

The product is a generic version of SpecGx LLC's Anafranil capsules in the same strengths, it added.

Drug firm Lupin on Monday said it has received approvals from the US health regulator for its Clomipramine Hydrochloride capsules, and Potassium Chloride for oral solution.

The product is a generic version of SpecGx LLC's Anafranil capsules in the same strengths, it added.

The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD), Lupin said. As per IQVIA MAT September 2018 data, Anafranil capsules in the same strengths had annual sales of around $109.6 million in the US, it added.

In a separate filing, Lupin said it has received approval from the USFDA to market its Potassium Chloride for oral solution USP, 20 mEq. The company's product is the generic version of Pharma Research Software Solution LLC's Potassium Chloride for oral solution, 20 mEq, it added. The product had annual sales of around $105 million in the US, Lupin said.

"It is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient," it added. Shares of Lupin were trading at Rs 835 per scrip on BSE, down 1.86 percent from the previous close.

Have you signed up for Primo, our daily newsletter?

It has all the stories and data on the market, business, economy and tech that you need to know.

To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

Lupin gets USFDA nod for antidepressant drug

You May Also Like

TVS Motor unveils its first electric two-wheeler with 75 km range; price starts at Rs 1.15 lakh

Have a plan to add 1,000-1,200 beds over next 3-4 years, says Ashutosh Raghuvanshi of Fortis Healthcare

Closing Bell: Sensex, Nifty end 1% lower on Coronavirus fears; metal, bank stocks drag

Trending on CNBC-TV18

recommended for you